Read about our response to COVID-19

Product Donations

It’s not enough to discover and develop new medicines and vaccines. We also need to help get them to the people who need them.



One important way to achieve the Sustainable Development Goal of improving health and well-being globally is through donations of medicines and vaccines that address specific health needs, whether in communities with a fundamental lack of access to health care and services or in acute or protracted humanitarian crises.

Our product donation programs and initiatives include:

MECTIZAN® (ivermectin) Donation Program
This program is one of the most significant initiatives undertaken by our company to help enable access to medicines in developing countries. Currently in its 32nd year, the MECTIZAN (ivermectin) Donation Program is the longest-running disease-specific drug donation program and public-private partnership of its kind.

Initially focused on control of onchocerciasis (river blindness), the company expanded the program in 1998 to include lymphatic filariasis (LF). Both diseases are now candidates for elimination, and our company is engaged in several global partnerships to help achieve that goal.

MSD Medical Outreach Program (MMOP)
Established over 60 years ago, our company’s Medical Outreach Program is the primary mechanism through which we donate our pharmaceuticals and vaccines for humanitarian aid in the developing world and in support of disaster relief and emergency response worldwide.

U.S. Patient Assistance Programs
Our Patient Assistance Program, a separately incorporated nonprofit charitable organization, provides selected medicines and adult vaccines for free to people who do not have prescription drug or health insurance coverage and who, without our assistance, could not otherwise afford them.